Indus Capital Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Indus Capital Partners’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-262,685	Closed	-$4.27M	–	30
2022 Q1	$4.27M	Buy	262,685 +101,393	+63%	+$2.6M	1.74%	9
2021 Q4	$7.64M	Sell	161,292 -84,964	-35%	-$5.1M	1.81%	14
2021 Q3	$17.9M	Sell	246,256 -62,939	-20%	-$4.55M	3.08%	11
2021 Q2	$26M	Sell	309,195 -186,794	-38%	-$12.3M	4.4%	5
2021 Q1	$24M	Buy	495,989 +363,453	+274%	+$19.7M	4.15%	7
2020 Q4	$6.25M	Buy	132,536 +31,183	+31%	+$1.23M	0.97%	29
2020 Q3	$4.77M	Buy	+101,353	New	+$3.34M	0.7%	34

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Indus Capital Partners's NBP Position: Q2 2022 in Review

Indus Capital Partners sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 262,685 shares — an estimated $4.27M sold.

Indus Capital Partners first reported a position in NBP in Q3 2020 and held it in 7 quarters. The position peaked at $26M in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

Indus Capital Partners reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Indus Capital Partners sold 262,685 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $4.27M.
Indus Capital Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 7 quarters.
Indus Capital Partners's NovaBridge Biosciences American Depositary Shares position peaked at $26M in Q2 2021.
97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Indus Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.